OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of BMS-986142, a reversible Bruton's tyrosine kinase inhibitor, for the treatment of rheumatoid arthritis: a phase 2, randomised, double-blind, dose-ranging, placebo-controlled, adaptive design study
Philip G. Conaghan, Miroslawa Nowak, Shuyan Du, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 5, pp. e263-e273
Open Access | Times Cited: 6

Showing 6 citing articles:

Bruton's Tyrosine Kinase – A New Target for Immune Mediated Inflammatory Diseases?
John D. Isaacs
Seminars in Arthritis and Rheumatism (2025), pp. 152681-152681
Open Access

Predicting kinase target inhibition level for efficacy in rheumatoid arthritis: a translational approach based on collagen-induced arthritis rodent studies
Rui Li, Roger S. Gifford, Peter T. Symanowicz, et al.
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103589-103589
Closed Access

Natural Products and Traditional Herbal Medicines as Managerial Therapies to Combat Rheumatoid Arthritis
Neha Ghosh, Shivam Pathak, Malsawmdawngkimi, et al.
Deleted Journal (2024) Vol. 22, Iss. 1
Closed Access | Times Cited: 3

The Immunomodulatory Mechanisms of BTK Inhibition in CLL and Beyond
Qu Jiang, Yayi Peng, Carmen D. Herling, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3574-3574
Open Access | Times Cited: 2

Bruton Tyrosine Kinase Inhibition Decreases Inflammation and Differentially Impacts Phagocytosis and Cellular Metabolism in Mouse- and Human-derived Myeloid Cells
Rochelle Y. Benoit, Jennifer L. Zagrodnik, Samantha J. Carew, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 9, pp. 652-667
Open Access

Et tu, Brutinib? Demise of a kinase target in rheumatoid arthritis?
Peter C. Taylor
The Lancet Rheumatology (2023) Vol. 5, Iss. 5, pp. e241-e243
Open Access

Page 1

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 6 citing articles:

Your Privacy